Utility of interrupting antiretroviral treatment before HIV drug resistance testing in patients with persistently detectable low-level viremia

被引：0
|
作者：
Sirvent, JLG [1 ]
Socas, MMA [1 ]
Calzadilla, CH [1 ]
Lirola, AML [1 ]
Valls, MRA [1 ]
机构：
[1] Hosp Univ Canarias, Lab Serv, Infect Dis Serv, Tenerife, Spain
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2005年 / 40卷 / 01期
关键词：
D O I：
10.1097/01.qai.0000174650.33159.22
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：111 / 113
页数：3
相关论文
共 50 条
  • [41] Significance and Clinical Management of Persistent Low-Level Viremia and Very-Low-Level Viremia in HIV-1-Infected Patients
    Ryscavage, Patrick
    Kelly, Sean
    Li, Jonathan Z.
    Harrigan, P. Richard
    Taiwo, Babafemi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 3585 - 3598
  • [42] Feasibility and clinical relevance of HIV-1 drug resistance testing in patients with low-level viraemia in South Africa
    Bangalee, Avania
    Hans, Lucia
    Steegen, Kim
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (10) : 2659 - 2665
  • [43] Detection of clinically relevant antiretroviral drug resistance mutations among treated patients undergoing testing at low levels of viremia
    Geretti, A. M.
    Phillips, A. N.
    Kaye, S.
    Booth, C.
    Mackie, N. E.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A60 - A60
  • [44] Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment
    Baroncelli, Silvia
    Pirillo, Maria F.
    Tamburrini, Enrica
    Guaraldi, Giovanni
    Pinnetti, Carmela
    Antoni, Anna Degli
    Galluzzo, Clementina M.
    Stentarelli, Chiara
    Amici, Roberta
    Floridia, Marco
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (07) : 673 - 678
  • [45] Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients
    Hofstra, Laura Marije
    Mudrikova, Tania
    Stam, Arjen J.
    Otto, Sigrid
    Tesselaar, Kiki
    Nijhuis, Monique
    Wensing, Annemarie M. J.
    PLOS ONE, 2014, 9 (10):
  • [46] Improved Viral Suppression After Treatment Optimization in HIV-Infected Patients With Persistent Low-Level Viremia
    McConnell, Michael J.
    Mier-Mota, Julian
    Flor-Parra, Fernando
    Martinez-Fernandez, Francisco J.
    Lopez-Cortes, Luis F.
    Viciana, Pompeyo
    Fernandez-Cuenca, Felipe
    Perez-Romero, Pilar
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 58 (05) : 446 - 449
  • [47] Low-level Viremia in Treated HIV-1 Infected Patients: Advances and Challenges
    Bai, Ruojing
    Lv, Shiyun
    Wu, Hao
    Dai, Lili
    CURRENT HIV RESEARCH, 2022, 20 (02) : 111 - 119
  • [48] HIV-1 Drug Resistance Profiles of Low-Level Viremia Patients and Factors Associated With the Treatment Effect of ART-Treated Patients: A Cross-Sectional Study in Jiangsu, China
    Yuan, Defu
    Zhou, Ying
    Shi, Lingen
    Liu, Yangyang
    Lu, Jing
    Chen, Jianshuang
    Fu, Gengfeng
    Wang, Bei
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [49] HIV-1 Genotypic Resistance Testing Using Sanger and Next-Generation Sequencing in Adults with Low-Level Viremia in China
    Li, Qun
    Yu, Fengting
    Song, Chuan
    Zhao, Hongxin
    Xiao, Qing
    Lao, Xiaojie
    Yang, Siyuan
    Tang, Yunxia
    Zhang, Fujie
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 6711 - 6722
  • [50] Durable HIV treatment benefit despite low-level viremia - Reassessing definitions of success or failure
    Deeks, SG
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (02): : 224 - 226
12345